Physician Assistant Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Michaela Lablanc

Physician Assistant, Surgical Albany, NY Physician Assistant

NPI 1174282677 CMS profile 11267026

1367 Washington Ave, Albany, NY 12206

Open in the dashboard

General payments

$4,058

27 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Michaela Lablanc of Albany, NY is reported in the CMS Open Payments database as having received $4,058 across 27 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Physician Assistant, Surgical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,662 11
2024 General $110 2
2023 General $1,086 13
2022 General $1,200 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michaela Lablanc
  • Physician Assistant, Surgical median
  • Middle half of Physician Assistant, Surgical
  • National median

In program year 2025, general payments to Michaela Lablanc were reported at $1,662. Among 8,152 Physician Assistant, Surgical profiles paid that year, the median was $146 and the middle half received between $51 and $385.

Show as a table
Year Michaela Lablanc Physician Assistant, Surgical median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $0 $111 $36–$285 $132
2022 $1,200 $126 $44–$350 $149
2023 $1,086 $137 $47–$355 $160
2024 $110 $146 $49–$384 $164
2025 $1,662 $146 $51–$385 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Prodigy Surgical Distribution, Inc. $1,670 3 payments
  2. Arthrex, Inc. $1,293 18 payments
  3. Sioux Surgical Inc $1,096 6 payments

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Travel and Lodging $2,153 7 payments
  2. Education $1,200 1 payment
  3. Food and Beverage $705 19 payments

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

269

Median for Physician Assistant: 241

Drug cost

$1,961

Median for Physician Assistant: $4,110

Branded share of claims

17.8%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone Hcl Generic 107 $583
Celecoxib Generic 19 $472
Ondansetron Odt Ondansetron Brand 36 $343
Cephalexin Generic 36 $221
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 12 $103
Tramadol Hcl Generic 30 $97
Omeprazole Generic 17 $94
Hydromorphone Hcl Generic 12 $48

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 78 billing codes

Paid by Medicare

$23,262

Of which drugs: $110

Medicare patients

174

Average age 73

Services billed

610

108 women, 66 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 66%
Arthritis 61%
Depression 20%
Osteoporosis 18%
Diabetes 17%
Ischemic heart disease 14%
Atrial fibrillation 14%
Cancer 13%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 33 142 $110

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

27 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Surgical in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record